help_outline Skip to main content

TCIM Research

The Combination of Four Main Components in Xuebijing Injection Improved the Preventive Effects

Ting Shang, Yue Guo, Xiu-Rong Li et al. | Published on 4/9/2022
Acute graft-versus-host disease (aGVHD) is a major life-threatening complication after Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT). Although a series of immunosuppressant agents are routinely used as the first-line prevention, the morbidity and mortality rate remains high in allo-HSCT recipients. Read more here.

All News / Articles